Association between cytokines and cerebral MRI changes in the aging brain

Journal of Geriatric Psychiatry and Neurology

Volumn 22, Issue 1, 2009, Pages 23-34

  Baune, Bernhard T ^a   Ponath, Gerald ^b   Rothermundt, Matthias ^b   Roesler, Andreas ^c   Berger, Klaus ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

Aging; Atrophy; Cytokines; Lacunar infarctions; White matter lesions

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ARTICLE; BODY MASS; BRAIN CORTEX ATROPHY; BRAIN INFARCTION; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

AGE DISTRIBUTION; AGED; AGING; ATROPHY; BRAIN; BRAIN INFARCTION; COMORBIDITY; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMANS; HYPERTENSION; INTERLEUKINS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PRINCIPAL COMPONENT ANALYSIS; SEX DISTRIBUTION; STROKE;

EID: 63049124965     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988708328216     Document Type: Article

References (66)

1. Scheltens P., Barkhof F., Valk J., et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain. 1992 ; 115 (pt 3). 735-748.
2. de Leeuw FE, de Groot JC, Achten E., et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001 ; 70: 9-14.
3. van Swieten JC, Staal S., Kappelle LJ, Derix MM, van Gijn J. Are white matter lesions directly associated with cognitive impairment in patients with lacunar infarcts ? J Neurol. 1996 ; 243: 196-200.
4. Yamauchi H., Fukuyama H., Shio H. Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment. Stroke. 2000 ; 31: 1515-1520.
5. Ylikoski A., Erkinjuntti T., Raininko R., Sarna S., Sulkava R., Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke. 1995 ; 26: 1171-1177.
6. Wiseman RM, Saxby BK, Burton EJ, Barber R., Ford GA, O'Brien JT Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology. 2004 ; 63: 1892-1897.
7. Sierra C. Cerebral white matter lesions in essential hypertension. Curr Hypertens Rep. 2001 ; 3: 429-433.
8. Gerdes VE, Kwa VI, ten Cate H., Brandjes DP, Buller HR, Stam J. Amsterdam Vascular Medicine Group. Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis. 2006 ; 186: 166-172.
9. Schmidt R., Launer LJ, Nilsson LG, et al. CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes. 2004 ; 53: 687-692.
10. Markus HS, Hunt B., Palmer K., Enzinger C., Schmidt H., Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke. 2005 ; 36: 1410-1414.
11. Macy EM, Hayes TE, Tracy RP Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997 ; 43: 52-58.
12. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 ; 342: 836-843.
13. Khreiss T., Jozsef L., Potempa LA, Filep JG Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. 2004 ; 109: 2016-2022.
14. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation. 2005 ; 112: 900-905.
15. van Dijk EJ, Prins ND, Vermeer SE, Koudstaal PJ, Breteler MM Frequency of white matter lesions and silent lacunar infarcts. J Neural Transm Suppl. (62) 2002: 25-39.
16. Vila N., Castillo J., Davalos A., Esteve A., Planas AM, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003 ; 34: 671-675.
17. Dziedzic T., Slowik A., Pera J., Szczudlik A. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovasc Dis. 2005 ; 20: 299-303.
18. Tomimoto H., Akiguchi I., Wakita H., et al. Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol (Berl). 1996 ; 92: 281-287.
19. Sindic CJ Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration. Bull Mem Acad R Med Belg. 2002 ; 157: 391-398 ; discussion 398-400.
20. Elenkov IJ, Iezzoni DG, Daly A., Harris AG, Chrousos GP Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005 ; 12: 255-269.
21. Hauss-Wegrzyniak B., Galons JP, Wenk GL Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation. Exp Neurol. 2000 ; 165: 347-354.
22. Jefferson AL, Massaro JM, Wolf PA, et al. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology. 2007 ; 68: 1032-1038.
23. Keil U., Liese AD, Hense HW Classical risk factors and their impact on incident non-fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Eur Heart J. 1998 ; 19: 1197-1207.
24. Schmidt WP, Roesler A., Kretzschmar K., Ladwig KH, Junker R., Berger K. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc. 2004 ; 52: 1045-1050.
25. Achten E., Breteler M., De Leeuw F. Rating scale for age related brain changes. Imaging Decision MRI. 2000 ; 4: 10-19.
26. Launer LJ, Oudkerk M., Nilsson LG, et al. CASCADE: a European collaborative study on vascular determinants of brain lesions. Study design and objectives. Neuroepidemiology. 2000 ; 19: 113-120.
27. Berger K., Kase CS, Buring JE Interobserver agreement in the classification of stroke in the physicians' health study. Stroke. 1996 ; 27: 238-242.
28. Berger K., Hense HW, Rothdach A., Weltermann B., Keil U. A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations. Neuroepidemiology. 2000 ; 19: 245-257.
29. Radloff LS The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977: 385-401.
30. de Leeuw FE, Korf E., Barkhof F., Scheltens P. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease. Stroke. 2006 ; 37: 2248-2252.
31. Liebetrau M., Hamann GF, Skoog I. White matter lesions as a risk factor for stroke and dementia. A population-based study in 85-year-olds. Nervenarzt. 2005 ; 76: 708-715.
32. Launer LJ Epidemiology of white-matter lesions. Int Psychogeriatr. 2003 ; 15 (suppl 1). 99-103.
33. Tarkowski E., Liljeroth AM, Minthon L., Tarkowski A., Wallin A., Blennow K. Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull. 2003 ; 61: 255-260.
34. Castellanos M., Castillo J., Garcia MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke. 2002 ; 33: 982-987.
35. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995 ; 37: 800-805.
36. Chou CY, Kuo HL, Lin HH, Liu JS, Liu YL, Huang CC C-reactive protein predicts ischaemic stroke in haemodialysis patients. Int J Clin Pract. 2007 (in press).
37. Guo Y., Jiang X., Chen S., Zhao HW, Gu KY C-reactive protein as an important prognostic marker for ischemic stroke. Zhonghua Yu Fang Yi Xue Za Zhi. 2003 ; 37: 102-104.
38. Guo Y., Jiang X., Zhou Z., Chen S., Zhao H., Li F. Relationship between levels of serum C-reactive protein, leucocyte count and carotid plaque in patients with ischemic stroke. J Huazhong Univ Sci Technolog Med Sci. 2003 ; 23: 263-265.
39. Hirabayashi K., Morikawa N., Mori H., et al. A 86-year-old woman with dementia, gait and speech disturbance, and right hemiparesis. No To Shinkei. 1995 ; 47: 803-812.
40. Reitz C., Berger K., de Maat MP, et al. CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study. Stroke. 2007 ; 38: 2356-2359.
41. Pinto A., Tuttolomondo A., Di Raimondo D., Fernandez P., Licata G. Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med. 2004 ; 4: 287-303.
42. Anderson VM, Fox NC, Miller DH Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging. 2006 ; 23: 605-618.
43. Richert ND, Howard T., Frank JA, et al. Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis. Neurology. 2006 ; 66: 551-556.
44. Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord. 1998 ; 12: 215-227.
45. Sjogren M., Folkesson S., Blennow K., Tarkowski E. Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J Neurol Neurosurg Psychiatry. 2004 ; 75: 1107-1111.
46. Bakshi R., Minagar A., Jaisani Z., Wolinsky JS Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx. 2005 ; 2: 277-303.
47. Csuka E., Morganti-Kossmann MC, Lenzlinger PM, Joller H., Trentz O., Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol. 1999 ; 101: 211-221.
48. Rafalowska J. HIV-1-infection in the CNS. A pathogenesis of some neurological syndromes in the light of recent investigations. Folia Neuropathol. 1998 ; 36: 211-216.
49. Narita M., Tanaka H., Togashi T., Abe S. Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae. Pediatr Neurol. 2005 ; 33: 105-109.
50. Melton LM, Keith AB, Davis S., Oakley AE, Edwardson JA, Morris CM Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia. 2003 ; 44: 1-12.
51. Mraovitch S. Isocortical hyperemia and allocortical inflammation and atrophy following generalized convulsive seizures of thalamic origin in the rat. Cell Mol Neurobiol. 2003 ; 23: 773-791.
52. Crews L., Wyss-Coray T., Masliah E. Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models. Brain Pathol. 2004 ; 14: 312-316.
53. Le Garrec M., Doret M., Pasquier JC, et al. Prenatal diagnosis of Aicardi-Goutieres syndrome. Prenat Diagn. 2005 ; 25: 28-30.
54. Lanzi G., D'Arrigo S., Drumbl G., Uggetti C., Fazzi E. Aicardi-Goutieres syndrome: differential diagnosis and aetiopathogenesis. Funct Neurol. 2003 ; 18: 71-75.
55. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A., Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991 ; 114 (pt 2). 761-774.
56. Fassbender K., Bertsch T., Mielke O., Muhlhauser F., Hennerici M. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke. 1999 ; 30: 1647-1650.
57. Hassan A., Hunt BJ, O'Sullivan M., et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003 ; 126: 424-432.
58. Vila E., Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol. 2005 ; 288: H1016 - H1021.
59. Charo IF, Taubman MB Chemokines in the pathogenesis of vascular disease. Circ Res. 2004 ; 95: 858-866.
60. Hauss-Wegrzyniak B., Vraniak PD, Wenk GL LPSinduced neuroinflammatory effects do not recover with time. Neuroreport. 2000 ; 11: 1759-1763.
61. Hauss-Wegrzyniak B., Vannucchi MG, Wenk GL Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res. 2000 ; 859: 157-166.
62. Lue LF, Rydel R., Brigham EF, et al. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia. 2001 ; 35: 72-79.
63. Tedgui A., Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res. 2001 ; 88: 877-887.
64. Ledeboer A., Breve JJ, Poole S., Tilders FJ, Van Dam AM Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia. 2000 ; 30: 134-142.
65. le Contel C., Parant F., Parant M. Indirect and selective down-regulation of serum tumor necrosis factor-alpha release by interleukin-1 beta. Immunobiology. 1992 ; 186: 199-213.
66. Remick DG Interleukin-8. Crit Care Med. 2005 ; 33: S466 - S467.